Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Nagoya

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Anticancer Research|May 1, 2007
LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcomaShintaro Takeda, Atsushi Iwai, Mitsuko Nakashima, et al.
Plos One|December 31, 2013
High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcomaMakoto Emori, Tomohide Tsukahara, Masaki Murase, et al.
International Orthopaedics|March 25, 2018
Quality of life of patients with osteonecrosis of the femoral head: a multicentre studyYuko Uesugi, Takashi Sakai, Taisuke Seki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substituteKazunori Ida, Satoshi Kawaguchi, Yuriko Sato, et al.
Cancer Science|June 26, 2012
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology GroupSatoshi Kawaguchi, Tomohide Tsukahara, Kazunori Ida, et al.
BMJ Open|March 29, 2024
Time elapsed from definitive diagnosis to surgery for osteonecrosis of the femoral head: a nationwide observational study in JapanJunichi Nakamura, Wakaba Fukushima, Wataru Ando, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Anticancer Research|May 1, 2007
LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcomaShintaro Takeda, Atsushi Iwai, Mitsuko Nakashima, et al.
Plos One|December 31, 2013
High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcomaMakoto Emori, Tomohide Tsukahara, Masaki Murase, et al.
International Orthopaedics|March 25, 2018
Quality of life of patients with osteonecrosis of the femoral head: a multicentre studyYuko Uesugi, Takashi Sakai, Taisuke Seki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substituteKazunori Ida, Satoshi Kawaguchi, Yuriko Sato, et al.
Cancer Science|June 26, 2012
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology GroupSatoshi Kawaguchi, Tomohide Tsukahara, Kazunori Ida, et al.
BMJ Open|March 29, 2024
Time elapsed from definitive diagnosis to surgery for osteonecrosis of the femoral head: a nationwide observational study in JapanJunichi Nakamura, Wakaba Fukushima, Wataru Ando, et al.
Pageof 7